Trial Profile
Correlation between intratumoral metabolic changes measured with 18F-FDG PET parametric response maps and concentrations of CC-223 in patients with glioblastoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Onatasertib (Primary)
- Indications Glioblastoma
- Focus Pharmacodynamics; Pharmacokinetics
- 31 Aug 2015 New trial record